PACIRA BIOSCIENCES, INC. Increase (Decrease) in Inventories
PACIRA BIOSCIENCES, INC. (PCRX) reported Increase (Decrease) in Inventories of -$8.45 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-04
- PACIRA BIOSCIENCES, INC. increase (decrease) in inventories for the quarter ending 2026-06-30 was -$5.96M, a 141.39% decline year-over-year.
- PACIRA BIOSCIENCES, INC. increase (decrease) in inventories for the quarter ending 2026-03-31 was -$2.49M, a 129.40% decline year-over-year.
- PACIRA BIOSCIENCES, INC. increase (decrease) in inventories for the quarter ending 2025-12-31 was -$4.82M, a 135.90% decline year-over-year.
- PACIRA BIOSCIENCES, INC. increase (decrease) in inventories for the quarter ending 2025-09-30 was $9.51M, a 12.89% increase year-over-year.
- PACIRA BIOSCIENCES, INC. increase (decrease) in inventories for fiscal 2025 was $27.57M, a 31.72% increase from fiscal 2024.
- PACIRA BIOSCIENCES, INC. increase (decrease) in inventories for fiscal 2024 was $20.93M, a 152.46% increase from fiscal 2023.
- PACIRA BIOSCIENCES, INC. increase (decrease) in inventories for fiscal 2023 was $8.29M.
- PACIRA BIOSCIENCES, INC. increase (decrease) in inventories for fiscal 2022 was -$2.49M, a 155.65% decline from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$5.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$8.45M 10-Q · filed 2026-08-04 | -$13.27M derived: sum of 3 quarters · filed 2026-08-04 | -$3.75M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$2.49M 10-Q · filed 2026-04-30 | -$7.31M derived: sum of 2 quarters · filed 2026-04-30 | $2.21M derived: sum of 3 quarters · filed 2026-04-30 | $16.60M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$4.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.70M derived: sum of 2 quarters · filed 2026-02-26 | $19.09M derived: sum of 3 quarters · filed 2026-08-04 | $27.57M 10-K · filed 2026-02-26 |
| 2025-09-30 | $9.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $23.91M derived: sum of 2 quarters · filed 2026-08-04 | $32.38M 10-Q · filed 2025-11-06 | $45.80M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $14.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $22.87M 10-Q · filed 2026-08-04 | $36.29M derived: sum of 3 quarters · filed 2026-08-04 | $44.72M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $8.47M 10-Q · filed 2026-04-30 | $21.89M derived: sum of 2 quarters · filed 2026-04-30 | $30.32M derived: sum of 3 quarters · filed 2026-04-30 | $36.97M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $13.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $21.84M derived: sum of 2 quarters · filed 2026-02-26 | $28.50M derived: sum of 3 quarters · filed 2026-02-26 | $20.93M 10-K · filed 2026-02-26 |
| 2024-09-30 | $8.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $15.08M derived: sum of 2 quarters · filed 2025-11-06 | $7.51M 10-Q · filed 2025-11-06 | $15.35M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $6.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$915.00K 10-Q · filed 2025-08-05 | $6.92M derived: sum of 3 quarters · filed 2026-02-26 | $11.31M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$7.57M 10-Q · filed 2025-05-08 | $261.00K derived: sum of 2 quarters · filed 2026-02-26 | $4.65M derived: sum of 3 quarters · filed 2026-02-26 | $3.80M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $7.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $12.22M derived: sum of 2 quarters · filed 2026-02-26 | $11.38M derived: sum of 3 quarters · filed 2026-02-26 | $8.29M 10-K · filed 2026-02-26 |
| 2023-09-30 | $4.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $3.54M derived: sum of 2 quarters · filed 2024-11-06 | $457.00K 10-Q · filed 2024-11-06 | -$278.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$847.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | -$3.93M 10-Q · filed 2024-07-30 | -$4.67M derived: sum of 3 quarters · filed 2025-02-27 | -$8.46M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$3.09M 10-Q · filed 2024-05-07 | -$3.82M derived: sum of 2 quarters · filed 2025-02-27 | -$7.61M derived: sum of 3 quarters · filed 2025-02-27 | -$10.68M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$735.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$4.52M derived: sum of 2 quarters · filed 2025-02-27 | -$7.60M derived: sum of 3 quarters · filed 2025-02-27 | -$2.49M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$3.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$6.86M derived: sum of 2 quarters · filed 2023-11-02 | -$1.75M 10-Q · filed 2023-11-02 | $156.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$3.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $2.04M 10-Q · filed 2023-08-02 | $3.94M derived: sum of 3 quarters · filed 2024-02-29 | $5.89M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $5.11M 10-Q · filed 2023-05-03 | $7.02M derived: sum of 2 quarters · filed 2024-02-29 | $8.96M derived: sum of 3 quarters · filed 2024-02-29 | $9.62M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $3.85M derived: sum of 2 quarters · filed 2024-02-29 | $4.51M derived: sum of 3 quarters · filed 2024-02-29 | $4.47M 10-K · filed 2024-02-29 |
| 2021-09-30 | $1.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $2.60M derived: sum of 2 quarters · filed 2022-11-03 | $2.56M 10-Q · filed 2022-11-03 | -$1.33M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $658.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $615.00K 10-Q · filed 2022-08-03 | -$3.28M derived: sum of 3 quarters · filed 2023-02-28 | -$1.43M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$43.00K 10-Q · filed 2022-05-04 | -$3.94M derived: sum of 2 quarters · filed 2023-02-28 | -$2.08M derived: sum of 3 quarters · filed 2023-02-28 | $4.94M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$3.89M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$2.04M derived: sum of 2 quarters · filed 2023-02-28 | $4.98M derived: sum of 3 quarters · filed 2023-02-28 | $6.35M 10-K · filed 2023-02-28 |
| 2020-09-30 | $1.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $8.88M derived: sum of 2 quarters · filed 2021-11-03 | $10.25M 10-Q · filed 2021-11-03 | $8.30M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $7.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $8.39M 10-Q · filed 2021-08-03 | $6.45M derived: sum of 3 quarters · filed 2022-02-28 | $13.90M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $1.37M 10-Q · filed 2021-05-04 | -$571.00K derived: sum of 2 quarters · filed 2022-02-28 | $6.88M derived: sum of 3 quarters · filed 2022-02-28 | $10.94M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $5.51M derived: sum of 2 quarters · filed 2022-02-28 | $9.57M derived: sum of 3 quarters · filed 2022-02-28 | $8.03M 10-K · filed 2022-02-28 |
| 2019-09-30 | $7.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $11.51M derived: sum of 2 quarters · filed 2020-10-30 | $9.97M 10-Q · filed 2020-10-30 | $13.65M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $4.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $2.52M 10-Q · filed 2020-08-06 | $6.20M derived: sum of 3 quarters · filed 2021-03-01 | $9.03M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | -$1.54M 10-Q · filed 2020-05-07 | $2.14M derived: sum of 2 quarters · filed 2021-03-01 | $4.97M derived: sum of 3 quarters · filed 2021-03-01 | $6.99M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $3.68M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $6.51M derived: sum of 2 quarters · filed 2021-03-01 | $8.53M derived: sum of 3 quarters · filed 2021-03-01 | $7.16M 10-K · filed 2021-03-01 |
| 2018-09-30 | $2.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $4.84M derived: sum of 2 quarters · filed 2019-11-08 | $3.47M 10-Q · filed 2019-11-08 | $5.77M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | $2.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $642.00K 10-Q · filed 2019-08-08 | $2.94M derived: sum of 3 quarters · filed 2020-02-21 | $8.45M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | -$1.37M 10-Q · filed 2019-05-02 | $931.00K derived: sum of 2 quarters · filed 2020-02-21 | $6.44M derived: sum of 3 quarters · filed 2020-02-21 | $9.73M derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $7.81M derived: sum of 2 quarters · filed 2020-02-21 | $11.10M derived: sum of 3 quarters · filed 2020-02-21 | $10.13M 10-K · filed 2020-02-21 |
| 2017-09-30 | $5.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $8.80M derived: sum of 2 quarters · filed 2018-11-01 | $7.83M 10-Q · filed 2018-11-01 | $1.64M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $3.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $2.32M 10-Q · filed 2018-08-02 | -$3.87M derived: sum of 3 quarters · filed 2019-02-28 | -$27.31M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | -$967.00K 10-Q · filed 2018-05-03 | -$7.17M derived: sum of 2 quarters · filed 2019-02-28 | -$30.61M derived: sum of 3 quarters · filed 2019-02-28 | -$33.43M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | -$6.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$29.64M derived: sum of 2 quarters · filed 2019-02-28 | -$32.47M derived: sum of 3 quarters · filed 2019-02-28 | -$30.37M 10-K · filed 2019-02-28 |
| 2016-09-30 | -$23.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$26.27M derived: sum of 2 quarters · filed 2017-11-08 | -$24.17M 10-Q · filed 2017-11-08 | -$18.66M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | -$2.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$729.00K 10-Q · filed 2017-08-02 | $4.78M derived: sum of 3 quarters · filed 2018-02-28 | $12.15M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $2.10M 10-Q · filed 2017-05-04 | $7.61M derived: sum of 2 quarters · filed 2018-02-28 | $14.97M derived: sum of 3 quarters · filed 2018-02-28 | $27.48M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $5.51M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $12.88M derived: sum of 2 quarters · filed 2018-02-28 | $25.38M derived: sum of 3 quarters · filed 2018-02-28 | $32.38M 10-K · filed 2018-02-28 |
| 2015-09-30 | $7.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $19.87M derived: sum of 2 quarters · filed 2016-11-02 | $26.87M 10-Q · filed 2016-11-02 | $40.58M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $12.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $19.51M 10-Q · filed 2016-08-04 | $33.21M derived: sum of 3 quarters · filed 2017-03-01 | $37.68M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $7.00M 10-Q · filed 2016-05-02 | $20.71M derived: sum of 2 quarters · filed 2017-03-01 | $25.18M derived: sum of 3 quarters · filed 2017-03-01 | $29.00M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $13.71M 10-K · filed 2017-03-01 | $18.17M derived: sum of 2 quarters · filed 2017-03-01 | $22.00M derived: sum of 3 quarters · filed 2017-03-01 | $13.71M 10-K · filed 2016-02-25 |
| 2014-09-30 | $4.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | $8.30M derived: sum of 2 quarters · filed 2015-10-27 | $8.11M 10-Q · filed 2015-10-27 | $8.06M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $3.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $3.64M 10-Q · filed 2015-07-30 | $3.59M derived: sum of 3 quarters · filed 2016-02-25 | $4.97M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | -$193.00K 10-Q · filed 2015-04-30 | -$242.00K derived: sum of 2 quarters · filed 2016-02-25 | $1.14M derived: sum of 3 quarters · filed 2016-02-25 | $4.60M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | -$49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $1.34M derived: sum of 2 quarters · filed 2016-02-25 | $4.80M derived: sum of 3 quarters · filed 2016-02-25 | $3.48M 10-K · filed 2016-02-25 |
| 2013-09-30 | $1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $4.85M derived: sum of 2 quarters · filed 2014-10-30 | $3.53M 10-Q · filed 2014-10-30 | $3.70M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | $3.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $2.14M 10-Q · filed 2014-07-31 | $2.31M derived: sum of 3 quarters · filed 2015-02-24 | $4.92M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | -$1.32M 10-Q · filed 2014-05-01 | -$1.15M derived: sum of 2 quarters · filed 2015-02-24 | $1.46M derived: sum of 3 quarters · filed 2015-02-24 | $5.68M derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | $171.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $2.78M derived: sum of 2 quarters · filed 2015-02-24 | $7.00M derived: sum of 3 quarters · filed 2015-02-24 | $10.83M 10-K · filed 2015-02-24 |
| 2012-09-30 | $2.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $6.83M derived: sum of 2 quarters · filed 2013-10-31 | $10.66M 10-Q · filed 2013-10-31 | $10.24M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-06-30 | $4.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $8.05M 10-Q · filed 2013-08-06 | $7.63M derived: sum of 3 quarters · filed 2014-02-25 | $7.42M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-03-31 | $3.83M 10-Q · filed 2013-05-08 | $3.41M derived: sum of 2 quarters · filed 2014-02-25 | $3.19M derived: sum of 3 quarters · filed 2014-02-25 | $3.30M derived: sum of 4 quarters · filed 2014-02-25 |
| 2011-12-31 | -$422.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$639.00K derived: sum of 2 quarters · filed 2014-02-25 | -$533.00K derived: sum of 3 quarters · filed 2014-02-25 | -$360.00K 10-K · filed 2014-02-25 |
| 2011-09-30 | -$217.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | -$111.00K derived: sum of 2 quarters · filed 2012-11-01 | $62.00K 10-Q · filed 2012-11-01 | $617.00K derived: sum of 4 quarters · filed 2013-03-07 |
| 2011-06-30 | $106.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $279.00K 10-Q · filed 2012-08-09 | $834.00K derived: sum of 3 quarters · filed 2013-03-07 | $686.00K derived: sum of 4 quarters · filed 2013-03-07 |
| 2011-03-31 | $173.00K 10-Q · filed 2012-05-09 | $728.00K derived: sum of 2 quarters · filed 2013-03-07 | $580.00K derived: sum of 3 quarters · filed 2013-03-07 | |
| 2010-12-31 | $555.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $407.00K derived: sum of 2 quarters · filed 2013-03-07 | -$124.00K 10-K · filed 2013-03-07 | |
| 2010-09-30 | -$148.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | -$679.00K 10-Q · filed 2011-10-31 | ||
| 2010-06-30 | -$531.00K 10-Q · filed 2011-08-11 | |||
| 2009-12-31 | -$299.00K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |